학술논문
1450P Addition of bevacizumab to first-line chemoimmunotherapy in NSCLC with liver metastases
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S824-S825
Subject
Language
ISSN
0923-7534